Abstract
Objective:
To investigate the safety and feasibility of single-port-plus-one (SP + 1) thoracoscopic lobectomy in the treatment of congenital pulmonary airway malformation (CPAM) in infants.
Methods:
The clinical data of 35 infants who underwent SP + 1 thoracoscopic lobectomy from May 2017 to December 2023 were retrospectively analyzed. The median age was 7 months, and the median weight was 8 kg. Included: 4 cases of upper lobectomy, 3 cases of middle lobectomy, and 28 cases of lower lobectomy.
Results:
SP + 1 thoracoscopic lobectomy was successfully completed in all infants. One case developed a postoperative air leak. There were no deaths and no other postoperative complications such as pulmonary infection, bleeding, atelectasis, bronchopleural fistula, and chylothorax.
Conclusion:
SP + 1 thoracoscopic lobectomy for infants with CPAM is safe, feasible, and cosmetic with satisfactory perioperative results in our preliminary experience.
Get full access to this article
View all access options for this article.